Weight loss jabs do not slow Alzheimer's disease as hoped, causing firm's share prices to plummet ⊕⊕
found
a story from The Daily Mail 💩 › The Daily Mail
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2025 › November › 24
Weight
8 months ago
Novo Nordisk had hoped to repurpose semaglutide - the active ingredient in its Wegovy and Ozempic jabs - as a groundbreaking dementia treatment after seeing early encouraging signs.
page 1 of 1